| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coregulator activity | 2.03e-04 | 562 | 73 | 9 | GO:0003712 | |
| GeneOntologyMolecularFunction | pre-mRNA 3'-splice site binding | 2.74e-04 | 7 | 73 | 2 | GO:0030628 | |
| GeneOntologyMolecularFunction | histone binding | 4.18e-04 | 265 | 73 | 6 | GO:0042393 | |
| GeneOntologyBiologicalProcess | protein-containing complex disassembly | 8.66e-06 | 291 | 73 | 8 | GO:0032984 | |
| GeneOntologyBiologicalProcess | neuron projection regeneration | 1.00e-05 | 81 | 73 | 5 | GO:0031102 | |
| GeneOntologyBiologicalProcess | cellular component disassembly | NRG1 HBS1L IGF1R GBF1 MAP1B APC SSRP1 ATAD2 SMCR8 MAP4K4 RUBCN | 1.04e-05 | 617 | 73 | 11 | GO:0022411 |
| GeneOntologyBiologicalProcess | positive regulation of cold-induced thermogenesis | 3.08e-05 | 102 | 73 | 5 | GO:0120162 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA-templated transcription, elongation | 6.90e-05 | 62 | 73 | 4 | GO:0032786 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle cell differentiation | 9.25e-05 | 25 | 73 | 3 | GO:2000725 | |
| GeneOntologyBiologicalProcess | axon regeneration | 1.05e-04 | 69 | 73 | 4 | GO:0031103 | |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex disassembly | 1.59e-04 | 144 | 73 | 5 | GO:0043244 | |
| GeneOntologyBiologicalProcess | regulation of cold-induced thermogenesis | 2.04e-04 | 152 | 73 | 5 | GO:0120161 | |
| GeneOntologyBiologicalProcess | cold-induced thermogenesis | 2.30e-04 | 156 | 73 | 5 | GO:0106106 | |
| GeneOntologyCellularComponent | transcription elongation factor complex | 3.93e-05 | 56 | 71 | 4 | GO:0008023 | |
| GeneOntologyCellularComponent | U2AF complex | 2.36e-04 | 7 | 71 | 2 | GO:0089701 | |
| GeneOntologyCellularComponent | intracellular protein-containing complex | ZZZ3 LEO1 CCDC47 POLR2C NFKBIA ARIH2 APC MCM3 REV3L SMCR8 CNOT3 | 4.11e-04 | 972 | 71 | 11 | GO:0140535 |
| HumanPheno | Abnormal hand morphology | SOX6 NPHP1 COL7A1 C2CD3 BRIP1 IGF1R ERCC6 TXNDC15 MAP1B KIF1A CCDC47 SMARCA2 APC CEP152 GNAS REV3L PQBP1 CNOT3 | 1.85e-07 | 1082 | 26 | 18 | HP:0005922 |
| HumanPheno | Abnormal 5th finger morphology | SOX6 NPHP1 C2CD3 BRIP1 TXNDC15 MAP1B CCDC47 SMARCA2 CEP152 GNAS REV3L PQBP1 CNOT3 | 2.61e-07 | 509 | 26 | 13 | HP:0004207 |
| HumanPheno | Abnormal finger morphology | SOX6 NPHP1 BMP1 COL7A1 C2CD3 BRIP1 IGF1R ERCC6 TXNDC15 MAP1B KIF1A CCDC47 SMARCA2 APC CEP152 GNAS REV3L PQBP1 CNOT3 | 1.37e-06 | 1385 | 26 | 19 | HP:0001167 |
| HumanPheno | Abnormal toe morphology | SOX6 BMP1 C2CD3 BRIP1 IGF1R GBF1 ERCC6 TXNDC15 KIF1A CCDC47 SMARCA2 APC CEP152 GNAS PQBP1 | 4.58e-06 | 893 | 26 | 15 | HP:0001780 |
| HumanPheno | Radial deviation of finger | SOX6 NPHP1 BRIP1 IGF1R MAP1B CCDC47 SMARCA2 CEP152 REV3L PQBP1 CNOT3 | 4.92e-06 | 448 | 26 | 11 | HP:0009466 |
| HumanPheno | Radial deviation of the hand or of fingers of the hand | SOX6 NPHP1 BRIP1 IGF1R MAP1B CCDC47 SMARCA2 CEP152 REV3L PQBP1 CNOT3 | 5.86e-06 | 456 | 26 | 11 | HP:0009485 |
| HumanPheno | Abnormal calvaria morphology | SOX6 NPHP1 BMP1 C2CD3 BRIP1 ERCC6 TXNDC15 MAP1B KIF1A CCDC47 NFKBIA SMARCA2 APC CEP152 GNAS PQBP1 CNOT3 | 1.24e-05 | 1254 | 26 | 17 | HP:0002683 |
| HumanPheno | Clinodactyly of the 5th finger | SOX6 NPHP1 BRIP1 MAP1B CCDC47 SMARCA2 CEP152 REV3L PQBP1 CNOT3 | 2.08e-05 | 420 | 26 | 10 | HP:0004209 |
| HumanPheno | Clinodactyly of hands | SOX6 NPHP1 BRIP1 MAP1B CCDC47 SMARCA2 CEP152 REV3L PQBP1 CNOT3 | 2.12e-05 | 421 | 26 | 10 | HP:0001157 |
| HumanPheno | Deviation of the 5th finger | SOX6 NPHP1 BRIP1 MAP1B CCDC47 SMARCA2 CEP152 REV3L PQBP1 CNOT3 | 2.12e-05 | 421 | 26 | 10 | HP:0009179 |
| HumanPheno | Abnormal hair quantity | SOX6 NPHP1 BMP1 COL7A1 IGF1R ERCC6 MAP1B CCDC47 NFKBIA SMARCA2 JAZF1 CEP152 GNAS PQBP1 | 2.62e-05 | 888 | 26 | 14 | HP:0011362 |
| HumanPheno | Deviation of finger | SOX6 NPHP1 BRIP1 IGF1R MAP1B CCDC47 SMARCA2 CEP152 REV3L PQBP1 CNOT3 | 2.84e-05 | 537 | 26 | 11 | HP:0004097 |
| HumanPheno | Finger clinodactyly | SOX6 NPHP1 BRIP1 MAP1B CCDC47 SMARCA2 CEP152 REV3L PQBP1 CNOT3 | 3.95e-05 | 452 | 26 | 10 | HP:0040019 |
| HumanPheno | Abnormal hair pattern | SOX6 NPHP1 BMP1 IGF1R ERCC6 MAP1B CCDC47 SMARCA2 APC GNAS PQBP1 CNOT3 | 4.41e-05 | 676 | 26 | 12 | HP:0010720 |
| HumanPheno | Deviation of the hand or of fingers of the hand | SOX6 NPHP1 BRIP1 IGF1R MAP1B CCDC47 SMARCA2 CEP152 REV3L PQBP1 CNOT3 | 4.52e-05 | 564 | 26 | 11 | HP:0009484 |
| HumanPheno | Clinodactyly | SOX6 NPHP1 BRIP1 IGF1R MAP1B CCDC47 SMARCA2 CEP152 REV3L PQBP1 CNOT3 | 5.34e-05 | 574 | 26 | 11 | HP:0030084 |
| HumanPheno | Abnormal hair morphology | SOX6 NPHP1 BMP1 COL7A1 BRIP1 IGF1R ERCC6 MAP1B CCDC47 NFKBIA SMARCA2 APC JAZF1 CEP152 GNAS PQBP1 CNOT3 | 7.48e-05 | 1424 | 26 | 17 | HP:0001595 |
| HumanPheno | Abnormality of the palpebral fissures | SOX6 NPHP1 BMP1 C2CD3 BRIP1 IGF1R ERCC6 CCDC47 SMARCA2 APC CEP152 PQBP1 CNOT3 | 1.27e-04 | 880 | 26 | 13 | HP:0008050 |
| HumanPheno | Dry hair | 1.27e-04 | 20 | 26 | 3 | HP:0011359 | |
| HumanPheno | Irregular hyperpigmentation | 1.36e-04 | 238 | 26 | 7 | HP:0007400 | |
| HumanPheno | Abnormal odontoid tissue morphology | 1.36e-04 | 238 | 26 | 7 | HP:3000050 | |
| HumanPheno | Abnormality of the dentition | NPHP1 BMP1 COL7A1 C2CD3 ERCC6 CCDC47 SH3BP2 NFKBIA SMARCA2 APC CEP152 GNAS REV3L PQBP1 | 1.46e-04 | 1030 | 26 | 14 | HP:0000164 |
| HumanPheno | Enamel hypoplasia | 1.51e-04 | 104 | 26 | 5 | HP:0006297 | |
| HumanPheno | Triangular face | 1.51e-04 | 167 | 26 | 6 | HP:0000325 | |
| HumanPheno | Abnormality of the outer ear | SOX6 NPHP1 BMP1 COL7A1 C2CD3 BRIP1 IGF1R ERCC6 TXNDC15 MAP1B CCDC47 SMARCA2 APC CEP152 PQBP1 CNOT3 | 1.54e-04 | 1337 | 26 | 16 | HP:0000356 |
| HumanPheno | Hypertrichosis | 1.55e-04 | 425 | 26 | 9 | HP:0000998 | |
| HumanPheno | Abnormal breast morphology | 2.06e-04 | 441 | 26 | 9 | HP:0031093 | |
| HumanPheno | Abnormal facial shape | SOX6 NPHP1 BMP1 C2CD3 BRIP1 IGF1R ERCC6 CCDC47 SH3BP2 SMARCA2 APC CEP152 GNAS PQBP1 CNOT3 | 2.28e-04 | 1221 | 26 | 15 | HP:0001999 |
| HumanPheno | Abnormality of the breast | 2.29e-04 | 447 | 26 | 9 | HP:0000769 | |
| HumanPheno | Abnormal eyelid morphology | SOX6 NPHP1 BMP1 C2CD3 BRIP1 IGF1R ERCC6 MAP1B CCDC47 SH3BP2 SMARCA2 APC CEP152 REV3L PQBP1 CNOT3 | 2.98e-04 | 1408 | 26 | 16 | HP:0000492 |
| HumanPheno | Abnormal long bone morphology | NPHP1 BMP1 BRIP1 ERCC6 TXNDC15 KIF1A CCDC47 SMARCA2 APC CEP152 GNAS REV3L | 3.04e-04 | 821 | 26 | 12 | HP:0011314 |
| HumanPheno | Hypoplasia of teeth | 3.71e-04 | 126 | 26 | 5 | HP:0000685 | |
| HumanPheno | Hypermelanotic macule | 4.16e-04 | 201 | 26 | 6 | HP:0001034 | |
| HumanPheno | Abnormality of hair texture | 4.64e-04 | 290 | 26 | 7 | HP:0010719 | |
| HumanPheno | Abnormal pinna morphology | SOX6 NPHP1 BMP1 C2CD3 BRIP1 IGF1R ERCC6 TXNDC15 MAP1B CCDC47 SMARCA2 APC CEP152 PQBP1 CNOT3 | 4.75e-04 | 1299 | 26 | 15 | HP:0000377 |
| HumanPheno | Cafe-au-lait spot | 5.46e-04 | 137 | 26 | 5 | HP:0000957 | |
| HumanPheno | Abnormal dental morphology | 5.59e-04 | 299 | 26 | 7 | HP:0006482 | |
| HumanPheno | Abnormal bone structure | NPHP1 BMP1 COL7A1 BRIP1 ERCC6 TXNDC15 KIF1A SH3BP2 NFKBIA APC CEP152 GNAS | 5.97e-04 | 881 | 26 | 12 | HP:0003330 |
| HumanPheno | Hirsutism | 6.12e-04 | 216 | 26 | 6 | HP:0001007 | |
| HumanPheno | Long fingers | 6.42e-04 | 306 | 26 | 7 | HP:0100807 | |
| HumanPheno | Abnormal dental enamel morphology | 6.91e-04 | 221 | 26 | 6 | HP:0000682 | |
| HumanPheno | Aplasia/hypoplasia involving the skeleton | SOX6 C2CD3 BRIP1 IGF1R ERCC6 TXNDC15 KIF1A CCDC47 SMARCA2 APC CEP152 GNAS REV3L PQBP1 CNOT3 | 6.99e-04 | 1343 | 26 | 15 | HP:0009115 |
| HumanPheno | Sparse or absent hair | 7.66e-04 | 525 | 26 | 9 | HP:0002115 | |
| HumanPheno | Abnormal palate morphology | SOX6 NPHP1 C2CD3 BRIP1 IGF1R TXNDC15 MAP1B CCDC47 SH3BP2 SMARCA2 APC CEP152 REV3L PQBP1 | 8.05e-04 | 1202 | 26 | 14 | HP:0000174 |
| HumanPheno | Abnormal number of teeth | 8.39e-04 | 421 | 26 | 8 | HP:0006483 | |
| HumanPheno | Abnormal hip bone morphology | 8.62e-04 | 653 | 26 | 10 | HP:0003272 | |
| HumanPheno | Anhidrosis | 8.85e-04 | 38 | 26 | 3 | HP:0000970 | |
| HumanPheno | Macule | 9.34e-04 | 234 | 26 | 6 | HP:0012733 | |
| HumanPheno | Hyperpigmentation of the skin | 9.74e-04 | 328 | 26 | 7 | HP:0000953 | |
| HumanPheno | High palate | SOX6 NPHP1 BRIP1 IGF1R MAP1B CCDC47 SMARCA2 APC CEP152 REV3L PQBP1 | 9.98e-04 | 794 | 26 | 11 | HP:0000218 |
| Domain | tRNA-bd_arm | 1.05e-04 | 24 | 72 | 3 | IPR010978 | |
| Domain | U2AF_small | 1.45e-04 | 5 | 72 | 2 | IPR009145 | |
| Domain | BROMODOMAIN_1 | 3.88e-04 | 37 | 72 | 3 | PS00633 | |
| Domain | Bromodomain | 4.21e-04 | 38 | 72 | 3 | PF00439 | |
| Domain | BROMODOMAIN_2 | 5.27e-04 | 41 | 72 | 3 | PS50014 | |
| Domain | BROMO | 5.66e-04 | 42 | 72 | 3 | SM00297 | |
| Domain | Bromodomain | 5.66e-04 | 42 | 72 | 3 | IPR001487 | |
| Domain | - | 5.66e-04 | 42 | 72 | 3 | 1.20.920.10 | |
| Domain | Pentatricopeptide_repeat | 3.52e-03 | 23 | 72 | 2 | IPR002885 | |
| Domain | Bromodomain_CS | 4.49e-03 | 26 | 72 | 2 | IPR018359 | |
| Domain | P-loop_NTPase | 5.15e-03 | 848 | 72 | 9 | IPR027417 | |
| Domain | SNF2_N | 6.75e-03 | 32 | 72 | 2 | IPR000330 | |
| Domain | SNF2_N | 6.75e-03 | 32 | 72 | 2 | PF00176 | |
| Pathway | REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX | 7.52e-05 | 58 | 55 | 4 | M805 | |
| Pathway | REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX | 8.05e-05 | 59 | 55 | 4 | MM14504 | |
| Pathway | WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR | 2.57e-04 | 32 | 55 | 3 | M39521 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 2.57e-04 | 32 | 55 | 3 | MM14975 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS | 2.76e-04 | 81 | 55 | 4 | M865 | |
| Pathway | REACTOME_HIV_ELONGATION_ARREST_AND_RECOVERY | 2.82e-04 | 33 | 55 | 3 | M27010 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS | 3.03e-04 | 83 | 55 | 4 | MM15314 | |
| Pubmed | SOX6 TXNDC15 BRD2 LEO1 KIF1A ZRSR2 TJP1 SUPT5H RALBP1 POLR2C ARIH2 APC CCDC15 REV3L MAP4K4 CTSL CNOT3 TRIM52 | 1.17e-10 | 1285 | 73 | 18 | 35914814 | |
| Pubmed | HDAC3 USP5 EAPP BRD2 LEO1 SUDS3 SUPT5H POLR2C ARIH2 CFDP1 SMARCA2 MCM3 SSRP1 PQBP1 HNRNPLL | 2.53e-09 | 1014 | 73 | 15 | 32416067 | |
| Pubmed | ELOF1 is a transcription-coupled DNA repair factor that directs RNA polymerase II ubiquitylation. | 2.86e-09 | 59 | 73 | 6 | 34108663 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | HDAC3 HBS1L LEO1 TJP1 PRCC SH3BP2 POLR2C NFKBIA EID1 GNAS SSRP1 MAP4K4 CNOT3 DENND4C | 2.93e-08 | 1038 | 73 | 14 | 26673895 |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | SOX6 HDAC3 BRIP1 ZZZ3 SUPT5H TLE2 POLR2C NFKBIA APC MCM3 PQBP1 CNOT3 | 2.75e-07 | 877 | 73 | 12 | 20211142 |
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | 1.27e-06 | 163 | 73 | 6 | 22113938 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | C2CD3 IGF1R GBF1 MAP1B TJP1 APC CEP152 GNAS SSRP1 MAP4K4 DENND4C | 1.77e-06 | 861 | 73 | 11 | 36931259 |
| Pubmed | 2.21e-06 | 282 | 73 | 7 | 23667531 | ||
| Pubmed | HDAC3 HBS1L ERCC6 BRD2 KIF1A CCDC47 POLR2C SMARCA2 APC SSRP1 ATAD2 PQBP1 HNRNPLL CNOT3 | 2.41e-06 | 1497 | 73 | 14 | 31527615 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 3.94e-06 | 588 | 73 | 9 | 38580884 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 33691379 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 34096589 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 11986329 | ||
| Pubmed | Zrsr2 and functional U12-dependent spliceosome are necessary for follicular development. | 4.35e-06 | 2 | 73 | 2 | 35198906 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 4.94e-06 | 774 | 73 | 10 | 15302935 | |
| Pubmed | USP5 IGF1R BRD2 TJP1 ARIH2 CEP152 ZNF428 GNAS PQBP1 RUBCN JMY DENND4C | 8.05e-06 | 1215 | 73 | 12 | 15146197 | |
| Pubmed | 9.14e-06 | 653 | 73 | 9 | 33742100 | ||
| Pubmed | Isolation and mapping of human homologues of an imprinted mouse gene U2af1-rs1. | 1.30e-05 | 3 | 73 | 2 | 8586425 | |
| Pubmed | Loss of cathepsin L activity promotes claudin-1 overexpression and intestinal neoplasia. | 1.30e-05 | 3 | 73 | 2 | 17622569 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 16371367 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 26364612 | ||
| Pubmed | Concurrent Zrsr2 mutation and Tet2 loss promote myelodysplastic neoplasm in mice. | 1.30e-05 | 3 | 73 | 2 | 36030305 | |
| Pubmed | ZO-1 expression shows prognostic value in chronic B cell leukemia. | 1.30e-05 | 3 | 73 | 2 | 26306999 | |
| Pubmed | Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer. | 1.30e-05 | 3 | 73 | 2 | 28591577 | |
| Pubmed | 1.45e-05 | 146 | 73 | 5 | 29688375 | ||
| Pubmed | 1.51e-05 | 251 | 73 | 6 | 29031500 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | BRD2 MAP1B ZRSR2 TJP1 SUPT5H POLR2C APC MCM3 SSRP1 MAP4K4 HNRNPLL | 1.53e-05 | 1082 | 73 | 11 | 38697112 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 2.08e-05 | 398 | 73 | 7 | 35016035 | |
| Pubmed | ATRX promotes heterochromatin formation to protect cells from G-quadruplex DNA-mediated stress. | 2.23e-05 | 26 | 73 | 3 | 34162889 | |
| Pubmed | Elongin A regulates transcription in vivo through enhanced RNA polymerase processivity. | 2.23e-05 | 26 | 73 | 3 | 33298525 | |
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 27458801 | ||
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 9001233 | ||
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 12595570 | ||
| Pubmed | Duration of nuclear NF-kappaB action regulated by reversible acetylation. | 2.60e-05 | 4 | 73 | 2 | 11533489 | |
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 19781646 | ||
| Pubmed | Suppression of colon cancer metastasis by Aes through inhibition of Notch signaling. | 2.60e-05 | 4 | 73 | 2 | 21251616 | |
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 7558001 | ||
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 33273014 | ||
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | 2.92e-05 | 420 | 73 | 7 | 28065597 | |
| Pubmed | Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2. | 3.48e-05 | 87 | 73 | 4 | 17148452 | |
| Pubmed | 3.76e-05 | 437 | 73 | 7 | 20562859 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 3.93e-05 | 440 | 73 | 7 | 34244565 | |
| Pubmed | SOX6 HDAC3 CHCHD4 ZZZ3 BRD2 PRCC SUDS3 NFKBIA CFDP1 SMARCA2 CEP152 CNOT3 | 3.99e-05 | 1429 | 73 | 12 | 35140242 | |
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 18502210 | ||
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 12972430 | ||
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 10912001 | ||
| Pubmed | 4.63e-05 | 33 | 73 | 3 | 12676794 | ||
| Pubmed | alphaII-Spectrin interacts with five groups of functionally important proteins in the nucleus. | 5.07e-05 | 34 | 73 | 3 | 16889989 | |
| Pubmed | 6.48e-05 | 6 | 73 | 2 | 20153290 | ||
| Pubmed | 6.48e-05 | 6 | 73 | 2 | 16481475 | ||
| Pubmed | FANCJ/BACH1 acetylation at lysine 1249 regulates the DNA damage response. | 6.48e-05 | 6 | 73 | 2 | 22792074 | |
| Pubmed | 6.48e-05 | 6 | 73 | 2 | 20531296 | ||
| Pubmed | 6.48e-05 | 6 | 73 | 2 | 18469135 | ||
| Pubmed | Minor intron retention drives clonal hematopoietic disorders and diverse cancer predisposition. | 6.48e-05 | 6 | 73 | 2 | 33846634 | |
| Pubmed | 6.59e-05 | 650 | 73 | 8 | 38777146 | ||
| Pubmed | PPP2R3A C2CD3 BRD2 LEO1 TJP1 CCDC47 SUPT5H CSPG5 POLR2C PQBP1 | 6.63e-05 | 1049 | 73 | 10 | 27880917 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | 7.35e-05 | 853 | 73 | 9 | 28718761 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | 7.72e-05 | 665 | 73 | 8 | 30457570 | |
| Pubmed | 9.06e-05 | 7 | 73 | 2 | 38383842 | ||
| Pubmed | 9.06e-05 | 7 | 73 | 2 | 29523594 | ||
| Pubmed | 9.06e-05 | 7 | 73 | 2 | 9237760 | ||
| Pubmed | 9.06e-05 | 7 | 73 | 2 | 27053111 | ||
| Pubmed | Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65. | 9.06e-05 | 7 | 73 | 2 | 12419806 | |
| Pubmed | 9.06e-05 | 7 | 73 | 2 | 22252316 | ||
| Pubmed | 9.20e-05 | 215 | 73 | 5 | 35973513 | ||
| Pubmed | 1.07e-04 | 222 | 73 | 5 | 37071664 | ||
| Pubmed | ZZZ3 ERCC6 BRD2 SUDS3 SH3BP2 POLR2C SMARCA2 JAZF1 REV3L SSRP1 | 1.10e-04 | 1116 | 73 | 10 | 31753913 | |
| Pubmed | BioID-based Identification of Skp Cullin F-box (SCF)β-TrCP1/2 E3 Ligase Substrates. | 1.16e-04 | 226 | 73 | 5 | 25900982 | |
| Pubmed | 1.19e-04 | 708 | 73 | 8 | 39231216 | ||
| Pubmed | 1.21e-04 | 8 | 73 | 2 | 32371981 | ||
| Pubmed | Regulation of NK cell-mediated cytotoxicity by the adaptor protein 3BP2. | 1.21e-04 | 8 | 73 | 2 | 11390470 | |
| Pubmed | Adaptor function for the Syk kinases-interacting protein 3BP2 in IL-2 gene activation. | 1.21e-04 | 8 | 73 | 2 | 9846481 | |
| Pubmed | 1.21e-04 | 8 | 73 | 2 | 23791194 | ||
| Pubmed | 1.21e-04 | 8 | 73 | 2 | 26345464 | ||
| Pubmed | 1.35e-04 | 47 | 73 | 3 | 29617656 | ||
| Pubmed | The OTUD5-UBR5 complex regulates FACT-mediated transcription at damaged chromatin. | 1.55e-04 | 9 | 73 | 2 | 30508113 | |
| Pubmed | 1.55e-04 | 9 | 73 | 2 | 19170756 | ||
| Pubmed | 1.56e-04 | 549 | 73 | 7 | 38280479 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 1.71e-04 | 954 | 73 | 9 | 36373674 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | HBS1L GBF1 KIF1A CCDC47 SUPT5H MCM3 GNAS SSRP1 ATAD2 MAP4K4 HNRNPLL | 1.81e-04 | 1425 | 73 | 11 | 30948266 |
| Pubmed | Essential role of Sox9 in the pathway that controls formation of cardiac valves and septa. | 1.93e-04 | 10 | 73 | 2 | 15096597 | |
| Pubmed | Human CFEOM1 mutations attenuate KIF21A autoinhibition and cause oculomotor axon stalling. | 1.93e-04 | 10 | 73 | 2 | 24656932 | |
| Pubmed | 1.93e-04 | 10 | 73 | 2 | 21055985 | ||
| Pubmed | 1.93e-04 | 10 | 73 | 2 | 21880767 | ||
| Pubmed | 1.93e-04 | 10 | 73 | 2 | 16902406 | ||
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | 1.98e-04 | 571 | 73 | 7 | 37167062 | |
| Pubmed | Spindle Assembly Checkpoint Inhibition Can Resensitize p53-Null Stem Cells to Cancer Chemotherapy. | 2.03e-04 | 137 | 73 | 4 | 30862715 | |
| Pubmed | 2.36e-04 | 11 | 73 | 2 | 31045206 | ||
| Pubmed | Binding of pRB to the PHD protein RBP2 promotes cellular differentiation. | 2.36e-04 | 11 | 73 | 2 | 15949438 | |
| Pubmed | 2.36e-04 | 11 | 73 | 2 | 22412988 | ||
| Pubmed | 2.36e-04 | 11 | 73 | 2 | 12190313 | ||
| Pubmed | 2.36e-04 | 11 | 73 | 2 | 22479204 | ||
| Pubmed | Targeting HIV transcription: the quest for a functional cure. | 2.36e-04 | 11 | 73 | 2 | 25731772 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | 2.62e-04 | 1242 | 73 | 10 | 30973865 | |
| Pubmed | 2.70e-04 | 1247 | 73 | 10 | 27684187 | ||
| Pubmed | AIP1/DAB2IP, a novel member of the Ras-GAP family, transduces TRAF2-induced ASK1-JNK activation. | 2.83e-04 | 12 | 73 | 2 | 15310755 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 2.88e-04 | 1024 | 73 | 9 | 24711643 | |
| Pubmed | 3.07e-04 | 62 | 73 | 3 | 19367581 | ||
| Pubmed | 3.10e-04 | 615 | 73 | 7 | 31048545 | ||
| Pubmed | 3.34e-04 | 13 | 73 | 2 | 22735158 | ||
| Interaction | CSNK2B interactions | ERCC6 BRD2 LEO1 TJP1 SUDS3 SUPT5H RALBP1 NFKBIA APC SSRP1 ATAD2 MAP4K4 | 2.00e-06 | 625 | 72 | 12 | int:CSNK2B |
| Interaction | ELOF1 interactions | 5.48e-06 | 71 | 72 | 5 | int:ELOF1 | |
| Interaction | H2BC21 interactions | C2CD3 ZZZ3 BRD2 LEO1 MAP1B SUPT5H POLR2C CFDP1 MCM3 SSRP1 ATAD2 MAP4K4 | 6.02e-06 | 696 | 72 | 12 | int:H2BC21 |
| Interaction | CSNK2A1 interactions | HDAC3 GBF1 BRD2 LEO1 PRCC SUDS3 SUPT5H NFKBIA CFDP1 APC MCM3 ZNF428 SSRP1 ATAD2 | 6.07e-06 | 956 | 72 | 14 | int:CSNK2A1 |
| Interaction | EP300 interactions | RPF1 HDAC3 USP5 HBS1L IGF1R LEO1 PRCC SUDS3 SUPT5H NFKBIA CFDP1 EID1 SMARCA2 MCM3 SSRP1 JMY CNOT3 | 6.52e-06 | 1401 | 72 | 17 | int:EP300 |
| Interaction | POLR2A interactions | ERCC6 LEO1 SUPT5H RALBP1 POLR2C NFKBIA SMARCA2 MCM3 SSRP1 PQBP1 | 1.99e-05 | 536 | 72 | 10 | int:POLR2A |
| Interaction | MTA3 interactions | 3.59e-05 | 173 | 72 | 6 | int:MTA3 | |
| Interaction | E2F2 interactions | 4.45e-05 | 55 | 72 | 4 | int:E2F2 | |
| Interaction | NCOR1 interactions | 4.50e-05 | 363 | 72 | 8 | int:NCOR1 | |
| Interaction | TOP2B interactions | 4.57e-05 | 266 | 72 | 7 | int:TOP2B | |
| Interaction | TASOR interactions | 4.62e-05 | 110 | 72 | 5 | int:TASOR | |
| Interaction | GOLGA1 interactions | 4.91e-05 | 183 | 72 | 6 | int:GOLGA1 | |
| Interaction | SNRPA interactions | 5.32e-05 | 482 | 72 | 9 | int:SNRPA | |
| Interaction | CDK2AP1 interactions | 6.47e-05 | 118 | 72 | 5 | int:CDK2AP1 | |
| Interaction | H3C1 interactions | HDAC3 BRIP1 ERCC6 BRD2 LEO1 RALBP1 CFDP1 EID1 SMARCA2 SSRP1 ATAD2 PQBP1 | 7.66e-05 | 901 | 72 | 12 | int:H3C1 |
| Interaction | E2F1 interactions | 8.03e-05 | 200 | 72 | 6 | int:E2F1 | |
| Interaction | HOOK3 interactions | 8.49e-05 | 202 | 72 | 6 | int:HOOK3 | |
| Interaction | BANF1 interactions | 8.96e-05 | 204 | 72 | 6 | int:BANF1 | |
| Interaction | COL7A1 interactions | 9.50e-05 | 25 | 72 | 3 | int:COL7A1 | |
| Interaction | SUPT4H1 interactions | 9.68e-05 | 67 | 72 | 4 | int:SUPT4H1 | |
| Interaction | TCEA1 interactions | 1.06e-04 | 131 | 72 | 5 | int:TCEA1 | |
| Interaction | ACTR3 interactions | 1.08e-04 | 305 | 72 | 7 | int:ACTR3 | |
| Interaction | POLR2E interactions | 1.15e-04 | 308 | 72 | 7 | int:POLR2E | |
| Interaction | PAF1 interactions | 1.16e-04 | 214 | 72 | 6 | int:PAF1 | |
| Interaction | HDAC3 interactions | 1.27e-04 | 313 | 72 | 7 | int:HDAC3 | |
| Interaction | TERF2IP interactions | 1.49e-04 | 552 | 72 | 9 | int:TERF2IP | |
| Interaction | INTS15 interactions | 1.49e-04 | 29 | 72 | 3 | int:INTS15 | |
| Interaction | PPP4R1 interactions | 1.58e-04 | 76 | 72 | 4 | int:PPP4R1 | |
| Interaction | TOP1 interactions | 1.76e-04 | 696 | 72 | 10 | int:TOP1 | |
| Interaction | CTR9 interactions | 1.85e-04 | 233 | 72 | 6 | int:CTR9 | |
| Interaction | ANKFY1 interactions | 1.98e-04 | 236 | 72 | 6 | int:ANKFY1 | |
| Interaction | RTF1 interactions | 2.00e-04 | 150 | 72 | 5 | int:RTF1 | |
| Interaction | POLR2J interactions | 2.13e-04 | 152 | 72 | 5 | int:POLR2J | |
| Interaction | POLR2D interactions | 2.19e-04 | 153 | 72 | 5 | int:POLR2D | |
| Interaction | RAD18 interactions | 2.21e-04 | 457 | 72 | 8 | int:RAD18 | |
| Interaction | NR0B2 interactions | 2.22e-04 | 83 | 72 | 4 | int:NR0B2 | |
| Interaction | GJA1 interactions | 2.24e-04 | 583 | 72 | 9 | int:GJA1 | |
| Interaction | SLC35G1 interactions | 2.42e-04 | 34 | 72 | 3 | int:SLC35G1 | |
| Interaction | PIPSL interactions | 2.82e-04 | 252 | 72 | 6 | int:PIPSL | |
| Interaction | SETD5 interactions | 3.11e-04 | 37 | 72 | 3 | int:SETD5 | |
| Interaction | RASA1 interactions | 3.29e-04 | 167 | 72 | 5 | int:RASA1 | |
| Interaction | HMGB1 interactions | 3.34e-04 | 486 | 72 | 8 | int:HMGB1 | |
| Interaction | DDA1 interactions | 3.40e-04 | 368 | 72 | 7 | int:DDA1 | |
| Interaction | H2AZ1 interactions | 3.57e-04 | 371 | 72 | 7 | int:H2AZ1 | |
| Interaction | POLR2B interactions | 3.57e-04 | 371 | 72 | 7 | int:POLR2B | |
| Interaction | ADAMTS1 interactions | 3.73e-04 | 95 | 72 | 4 | int:ADAMTS1 | |
| Interaction | CENPA interactions | 3.93e-04 | 377 | 72 | 7 | int:CENPA | |
| Interaction | CRNKL1 interactions | 4.29e-04 | 177 | 72 | 5 | int:CRNKL1 | |
| Interaction | WDR76 interactions | 4.32e-04 | 383 | 72 | 7 | int:WDR76 | |
| Interaction | H2BC1 interactions | 4.41e-04 | 178 | 72 | 5 | int:H2BC1 | |
| Interaction | ZRSR2P1 interactions | 4.46e-04 | 9 | 72 | 2 | int:ZRSR2P1 | |
| Interaction | POLR2G interactions | 4.52e-04 | 179 | 72 | 5 | int:POLR2G | |
| Interaction | CEP152 interactions | 4.52e-04 | 179 | 72 | 5 | int:CEP152 | |
| Interaction | LEO1 interactions | 4.76e-04 | 278 | 72 | 6 | int:LEO1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q21 | 1.89e-04 | 177 | 73 | 4 | chr15q21 | |
| Cytoband | 15q21.1 | 1.60e-03 | 37 | 73 | 2 | 15q21.1 | |
| Coexpression | GSE19401_PAM2CSK4_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_DN | 1.26e-06 | 196 | 73 | 7 | M7672 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | NPHP1 HDAC3 FOXRED2 BRIP1 KIF1A CSPG5 JAZF1 MCM3 REV3L SSRP1 ATAD2 | 2.73e-06 | 680 | 73 | 11 | MM456 |
| Coexpression | WANG_TUMOR_INVASIVENESS_UP | 1.16e-05 | 384 | 73 | 8 | M1865 | |
| Coexpression | WANG_TUMOR_INVASIVENESS_UP | 1.61e-05 | 402 | 73 | 8 | MM1248 | |
| Coexpression | PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP | 1.77e-05 | 195 | 73 | 6 | M13736 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.29e-06 | 184 | 73 | 7 | gudmap_developingGonad_e14.5_ epididymis_1000_k2 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.23e-07 | 186 | 73 | 6 | 10565fce7e1b4ec88bc8e1ed6410a83800be5014 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.21e-07 | 195 | 73 | 6 | bd8e24dd598990204998d1dd853ba7a53dc0107e | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.24e-07 | 199 | 73 | 6 | 1d5a3366474c17e3df0ba5cf11b586655529e9bd | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.56e-05 | 191 | 73 | 5 | 50854384fdaa0efa2e3227659d544ed09ac102f2 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.72e-05 | 195 | 73 | 5 | b65463a804fed2d9a3be9e528ca8b9c98469bc86 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.72e-05 | 195 | 73 | 5 | 56d8734d020b3da08a5aa9e67999706a9e023a99 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.76e-05 | 196 | 73 | 5 | df366d76ea55f49e349d622effa57c1535df8400 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Proliferating_Epithelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.89e-05 | 199 | 73 | 5 | 4fcf5bec207e4384fd73c5e8801a7e414e3ee7b0 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.89e-05 | 199 | 73 | 5 | 5d2e85e40b6b52b1809e680b952913d77215b3d0 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.89e-05 | 199 | 73 | 5 | 9dd4b17fb8c70ab9e126b23b72600463f3db832d | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.89e-05 | 199 | 73 | 5 | 6fb5f931e6217142de38c1fffc011e63bda4772b | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.89e-05 | 199 | 73 | 5 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.89e-05 | 199 | 73 | 5 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.89e-05 | 199 | 73 | 5 | 1bb5797e8e0552bf9b44bf4c958d1aa6dbe6c756 | |
| ToppCell | 10x_3'_v2v3-Neoplastic|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.94e-05 | 200 | 73 | 5 | e9c7d7cb5fa63fc92aa91d02ae8bd05438d465bc | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Stem_cells-Neuroepithelial_cell|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 1.94e-05 | 200 | 73 | 5 | 4e077aa7faddcebdfc54667f8b3990704441005b | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.94e-05 | 200 | 73 | 5 | af3dc76b4507bf4edd265169f5dfbbb8a19eb394 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 1.94e-05 | 200 | 73 | 5 | d17ba4239e1fd702a3d757687110f0f2c6f91ef7 | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 9.73e-05 | 146 | 73 | 4 | a317f14a1aab11ffcce65baeb1c475c04324315f | |
| ToppCell | Adult-Immune-enucleated_erythrocyte-D175|Adult / Lineage, Cell type, age group and donor | 1.14e-04 | 152 | 73 | 4 | 530d5427d8617dcb223d807b73abee0ef89285f3 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.39e-04 | 160 | 73 | 4 | 5cc1b75e3c20d83112b3aa2f3c749a6c73910a2d | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.52e-04 | 164 | 73 | 4 | 5621c2e3fae84d5a2e4f1595e454bcb3a2b3f93c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-04 | 165 | 73 | 4 | 88681101d7cf60b99b8ace5d8c0944323b937306 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.63e-04 | 167 | 73 | 4 | 3461d14e36f09ddc6ee5549ca4797e16d3f37fcc | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.67e-04 | 168 | 73 | 4 | a1755afa2cc50960ba60e07d84d61be429cdea72 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.67e-04 | 168 | 73 | 4 | a7eb28e15b591997f1aee09501cb20ae18beca08 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l15|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.67e-04 | 168 | 73 | 4 | a8958b94ffc3423d56c250796dd253884b46f9d9 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.71e-04 | 169 | 73 | 4 | c3bf0cb67f200d02d5a021754e9b2a68d23ea168 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.71e-04 | 169 | 73 | 4 | a1efc20e34a81ae32f8d278a5486811ade03ef24 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)--|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.71e-04 | 169 | 73 | 4 | 5375eb52ebadccb7bfff997a11985f23e81014d6 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.71e-04 | 169 | 73 | 4 | 1c132d21255f5a5174ac38db4e91927f9093418e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-04 | 171 | 73 | 4 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-04 | 171 | 73 | 4 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.95e-04 | 175 | 73 | 4 | e99e145a152f534b75267ec492a252a0b814b4f8 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-04 | 177 | 73 | 4 | f925a15d2162d166a5b60edac3517c6b2d6cfbea | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.04e-04 | 177 | 73 | 4 | 6b4fe717928814dafcd13090b1c90ea973938c6d | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 177 | 73 | 4 | ea2c2d2d7ffd34780882299229ff8614fdd7c79c | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 177 | 73 | 4 | 63b5ebbe505f22091bc7b0db818e01fae5d92bb7 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.08e-04 | 178 | 73 | 4 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 178 | 73 | 4 | 30ca37f70d267cc9b40ca3e211f16d30360c3e6b | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-04 | 179 | 73 | 4 | 8ebd0c7ac99ac8194fa1a2aac88a893739a97725 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Ly6g5b+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 180 | 73 | 4 | 81c7086399256260e59424b7410feec514ce8027 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-immature_innate_lymphoid_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.22e-04 | 181 | 73 | 4 | c7ad10a696d94b9ee91cd7e62761d356d5106eda | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-immature_innate_lymphoid_cell-Ly6g5b+_T|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.22e-04 | 181 | 73 | 4 | eaa3a2c268cce527004ae656d35e037b984fb4c7 | |
| ToppCell | PBMC-Control-cDC_12|Control / Compartment, Disease Groups and Clusters | 2.27e-04 | 182 | 73 | 4 | 4774066d0f9986abc3d13a2a3bc99ce4f1327ae0 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Cycling_T|Liver / Manually curated celltypes from each tissue | 2.27e-04 | 182 | 73 | 4 | 81557cdc88777f3bd4e1dd18a760b08fc29122ef | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 183 | 73 | 4 | ad7421623e4c0c5ba02eec56e9bdae43ebb88d90 | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Cycling_pre-Myeloid-1|lymph-node_spleen / Manually curated celltypes from each tissue | 2.36e-04 | 184 | 73 | 4 | f93373fcde5c31f4ffe67ca0f3ea7f4e906dc88b | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-04 | 184 | 73 | 4 | 3da93e7d8b62463e307cc0425c47dbd3bef66799 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-04 | 184 | 73 | 4 | 278a7ed764c326450cb70e69ed2175980eaf5fe0 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-04 | 184 | 73 | 4 | 8d86e125257ff1d3af8d90577a8b3f0321eca21c | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_neuroendocrine2[NE2]_(12)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.46e-04 | 186 | 73 | 4 | c7983281a290201567b398e9ea6baddb96c692bb | |
| ToppCell | Nasal_Brush-Immune-Neutrophils|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.46e-04 | 186 | 73 | 4 | f5aa91dbef29f7efa2b9a728c6539d7541340cd4 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-04 | 186 | 73 | 4 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-04 | 187 | 73 | 4 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | COVID-19-kidney|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.51e-04 | 187 | 73 | 4 | d23aae9419d460b78b1d4092d7acd9108a47cfbe | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-04 | 187 | 73 | 4 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.57e-04 | 188 | 73 | 4 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-04 | 188 | 73 | 4 | 006db2c2c44971ca9241c582bc89f258c785f5ed | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-04 | 188 | 73 | 4 | d0e6fb4a3b3d79d3512b5500062ea285495ae526 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_neuroendocrine1[NE1]_(11)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.67e-04 | 190 | 73 | 4 | b1095b2a7467c152d16e4f19a9515aeb61fc9e3d | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-04 | 191 | 73 | 4 | f76f3f5c7902a3659d8cbe470f96ce57c8a6744d | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-04 | 192 | 73 | 4 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.78e-04 | 192 | 73 | 4 | 1d0d6fb89a2b941b7caab2f1f07d6bd5433a11e7 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.83e-04 | 193 | 73 | 4 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.83e-04 | 193 | 73 | 4 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.83e-04 | 193 | 73 | 4 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | facs-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.83e-04 | 193 | 73 | 4 | 15c86e20b97b6983410b36d308cddff56d141c98 | |
| ToppCell | Non-neuronal-Non-dividing|World / Primary Cells by Cluster | 2.89e-04 | 194 | 73 | 4 | 0add09d97192b34bd506209ab5f1a77182f498fc | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.89e-04 | 194 | 73 | 4 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.89e-04 | 194 | 73 | 4 | 8985095f291c1b54e45f4edece49aa26e8c8b732 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.89e-04 | 194 | 73 | 4 | 4c1d13d8cb6fb424655c67755ee6dbaf59d6b418 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.89e-04 | 194 | 73 | 4 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.89e-04 | 194 | 73 | 4 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|Liver / Manually curated celltypes from each tissue | 2.95e-04 | 195 | 73 | 4 | 972b09697b7b66fb8a27dfc0c0b05a844121f055 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.95e-04 | 195 | 73 | 4 | cec7df321f372d05c94f97d6bb18891a5cc3dec3 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo|Liver / Manually curated celltypes from each tissue | 2.95e-04 | 195 | 73 | 4 | c29c4ae95a756e3ced0f0747bbfe343590e5b8ab | |
| ToppCell | Control-Lymphoid-CD4_T_cells|Lymphoid / Condition, Lineage and Cell class | 2.95e-04 | 195 | 73 | 4 | 8679a122fe796b1eddef82460e985b3fd3b3a2a5 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-basal_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-04 | 195 | 73 | 4 | eaadc79f53b1cb208c6f7999925f318e1378197f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.01e-04 | 196 | 73 | 4 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.01e-04 | 196 | 73 | 4 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.06e-04 | 197 | 73 | 4 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.06e-04 | 197 | 73 | 4 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.06e-04 | 197 | 73 | 4 | 8b616cde333bdbc0c591035ad9e4949155866245 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast-(8)_Smooth_muscle_cells|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.06e-04 | 197 | 73 | 4 | 4e0c3ea4f4a04a41532806edf3bccf7845c86fa5 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 3.06e-04 | 197 | 73 | 4 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.06e-04 | 197 | 73 | 4 | 7870c0651caefb0ed13d9f9dab43b5f24d6a9efc | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 3.12e-04 | 198 | 73 | 4 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | Healthy_Control-Myeloid-Macrophages-FCN1+SPP1+|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 3.12e-04 | 198 | 73 | 4 | aa90326b82e21de37af5642df6a70a8b21af7f04 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 3.18e-04 | 199 | 73 | 4 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M|organoid_Kanton_Nature / Sample Type, Dataset, Time_group, and Cell type. | 3.18e-04 | 199 | 73 | 4 | b2d7dea11207cca63d688f8051143850b29dbdf0 | |
| ToppCell | COVID-19_Mild-T/NK_proliferative|COVID-19_Mild / Disease condition and Cell class | 3.18e-04 | 199 | 73 | 4 | 9f9a88d2b099646c1e1a7ee3f8d39cb1a2498ad7 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Severe / Disease group, lineage and cell class | 3.18e-04 | 199 | 73 | 4 | ddae7fe7633661f15d3c79f5187415ffbfecce67 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 3.18e-04 | 199 | 73 | 4 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | ILEUM-non-inflamed-(8)_Smooth_muscle_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.18e-04 | 199 | 73 | 4 | 3368c0a90a47c4dcdfe70be3192550df0744e508 | |
| ToppCell | COVID-19_Severe-T/NK_proliferative|COVID-19_Severe / disease group, cell group and cell class | 3.18e-04 | 199 | 73 | 4 | af78837f3a7641a5bd98765eef9cb4f86034048c | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.18e-04 | 199 | 73 | 4 | 94baf00dad27964392c3fc34970a4e79d576d0d3 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells-Neuroepithelial_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | 3.24e-04 | 200 | 73 | 4 | 8f8b8c225cdc79baf16fe04be89bdb65e404a055 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 3.24e-04 | 200 | 73 | 4 | d933978b55fefe52cad599b36f6b47a0c7f71f96 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells|10w / Sample Type, Dataset, Time_group, and Cell type. | 3.24e-04 | 200 | 73 | 4 | a1f48eca9efb4f3ec3c9ace20f8c9257dd72c4ed | |
| Drug | Dyclonine hydrochloride [536-43-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 3.17e-06 | 196 | 73 | 7 | 7022_DN | |
| Drug | Ethopropazine hydrochloride [1094-08-2]; Up 200; 11.4uM; PC3; HT_HG-U133A | 3.34e-05 | 190 | 73 | 6 | 6697_UP | |
| Drug | Piribedil hydrochloride [78213-63-5]; Down 200; 12uM; MCF7; HT_HG-U133A | 3.44e-05 | 191 | 73 | 6 | 5434_DN | |
| Drug | GW8510; Up 200; 10uM; MCF7; HT_HG-U133A | 3.54e-05 | 192 | 73 | 6 | 7062_UP | |
| Drug | (1)-Nipecotic acid [498-95-3]; Down 200; 31uM; HL60; HT_HG-U133A | 3.97e-05 | 196 | 73 | 6 | 3121_DN | |
| Drug | Hydroquinine hydrobromide hydrate [304695-81-6]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 3.97e-05 | 196 | 73 | 6 | 6263_DN | |
| Drug | Hydrastine hydrochloride [5936-28-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 3.97e-05 | 196 | 73 | 6 | 2889_DN | |
| Drug | Oxantel pamoate [68813-55-8]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 3.97e-05 | 196 | 73 | 6 | 5338_UP | |
| Drug | Flutamide [13311-84-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 4.09e-05 | 197 | 73 | 6 | 3885_DN | |
| Drug | Sulfamonomethoxine [1220-83-3]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 4.09e-05 | 197 | 73 | 6 | 3484_UP | |
| Drug | 5186223; Down 200; 12uM; MCF7; HT_HG-U133A_EA | 4.09e-05 | 197 | 73 | 6 | 885_DN | |
| Drug | Lithocholic acid [434-13-9]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 4.21e-05 | 198 | 73 | 6 | 3433_UP | |
| Drug | Monensin sodium salt [22373-78-0]; Down 200; 5.8uM; HL60; HT_HG-U133A | 4.21e-05 | 198 | 73 | 6 | 2580_DN | |
| Drug | Epicatechin-(-) [154-23-4]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 4.21e-05 | 198 | 73 | 6 | 2815_DN | |
| Drug | Nicergoline; Down 200; 8.2uM; MCF7; HT_HG-U133A | 4.33e-05 | 199 | 73 | 6 | 2220_DN | |
| Drug | Ticlopidine hydrochloride [53885-35-1]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 4.33e-05 | 199 | 73 | 6 | 1475_DN | |
| Drug | Metformin hydrochloride [1115-70-4]; Down 200; 24.2uM; PC3; HT_HG-U133A | 4.33e-05 | 199 | 73 | 6 | 5068_DN | |
| Drug | Betaxolol hydrochloride [63659-19-8]; Down 200; 11.6uM; HL60; HG-U133A | 4.45e-05 | 200 | 73 | 6 | 1592_DN | |
| Drug | Florfenicol [73231-34-2]; Up 200; 11.2uM; PC3; HT_HG-U133A | 4.45e-05 | 200 | 73 | 6 | 6701_UP | |
| Disease | Growth Disorders | 8.63e-05 | 36 | 70 | 3 | C0018273 | |
| Disease | dementia (is_implicated_in) | 3.61e-04 | 12 | 70 | 2 | DOID:1307 (is_implicated_in) | |
| Disease | Alzheimer's disease (is_marker_for) | 3.68e-04 | 257 | 70 | 5 | DOID:10652 (is_marker_for) | |
| Disease | colorectal cancer (is_marker_for) | 5.38e-04 | 157 | 70 | 4 | DOID:9256 (is_marker_for) | |
| Disease | cryptococcosis | 5.71e-04 | 15 | 70 | 2 | EFO_0007229 | |
| Disease | thyroid volume | 6.52e-04 | 16 | 70 | 2 | EFO_0004865 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 9.16e-04 | 181 | 70 | 4 | DOID:684 (is_implicated_in) | |
| Disease | Giant Cell Glioblastoma | 1.06e-03 | 84 | 70 | 3 | C0334588 | |
| Disease | cholangiocarcinoma (is_implicated_in) | 1.24e-03 | 22 | 70 | 2 | DOID:4947 (is_implicated_in) | |
| Disease | sciatic neuropathy (implicated_via_orthology) | 1.36e-03 | 23 | 70 | 2 | DOID:11446 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | 1.37e-03 | 702 | 70 | 7 | C0009402 | |
| Disease | tyrosine measurement | 1.96e-03 | 104 | 70 | 3 | EFO_0005058 | |
| Disease | asthma | 2.01e-03 | 751 | 70 | 7 | MONDO_0004979 | |
| Disease | hyperthyroidism (biomarker_via_orthology) | 2.02e-03 | 28 | 70 | 2 | DOID:7998 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PVQNEDEEYDEEDYE | 11 | O94986 | |
| YPTTSFYDDLDEEEE | 266 | O95196 | |
| PYPTDNEDYEHDDED | 166 | P78314 | |
| DDYDPYAVEEPSDEE | 6 | Q56P03 | |
| EEEEDDPGDIEDYYV | 26 | O95376 | |
| SDLAYSDDDVPSVYE | 746 | Q6PL18 | |
| ADYTYDLAEEDDSEP | 26 | P13497 | |
| DPPVDLSSDEEYYVE | 166 | Q5BKX8 | |
| DSEGEESEYFPTEEE | 366 | Q03468 | |
| DVEYYVDSSQDPDFE | 206 | O75175 | |
| AYDREESTNLEDYEP | 246 | Q15311 | |
| SSPRETYEEDREYES | 6 | Q8WVV9 | |
| DKPSVEPVEEYDYED | 46 | Q9Y450 | |
| EPVEEYDYEDLKESS | 51 | Q9Y450 | |
| EDEEYETTQEYEPAQ | 521 | Q02297 | |
| DSEGEESEYFPTEEE | 366 | P0DP91 | |
| YEYSGSEEEEEEVPE | 321 | O95819 | |
| SASYLEPDRYDEEEE | 566 | Q8WVC0 | |
| EETTRSPDEEDYDYE | 1876 | P46821 | |
| SPDEEDYDYESYEKT | 1881 | P46821 | |
| TETDDPEEYYESLSE | 311 | Q8N9B5 | |
| PAYPESFDQDTEDDE | 406 | Q8N6Y2 | |
| YPDLYPQEDEDEEEE | 101 | Q8N4Q1 | |
| TPTGSEYDEEEVDYE | 126 | Q86VZ6 | |
| DTESEPYDDEEFEGY | 91 | Q96A33 | |
| DTYNITDPEELETEY | 761 | P08069 | |
| EDDYDYPEEEQLSGA | 106 | Q9Y6B2 | |
| PESEDEESYDTESEF | 281 | P25963 | |
| EYAEGYESVSVDPED | 196 | Q8IWF2 | |
| FEDYETDEPASPSEF | 1111 | Q06190 | |
| EEAISEELPYSEYFE | 316 | O15379 | |
| EDESIYFTPELYDPE | 1126 | Q9BX63 | |
| YFTPELYDPEDTDEE | 1131 | Q9BX63 | |
| DGDSYDPYDFSDTEE | 701 | P25205 | |
| EEIIAEDYDDDPVDY | 26 | O60828 | |
| EDYDDDPVDYEATRL | 31 | O60828 | |
| SEDFSTSEEDEDYVP | 6 | Q9UEE9 | |
| EDTEAGPAYSDEDYE | 2051 | Q4AC94 | |
| GPAYSDEDYEEDIIE | 2056 | Q4AC94 | |
| LEYEEEFDYETESET | 101 | O95467 | |
| YSDDEEETNRDYSFP | 1386 | Q5VZ89 | |
| VTPDEETYDEEDAAF | 1141 | Q92538 | |
| EEERVPPEDDEYSEY | 2841 | Q02388 | |
| PPEDDEYSEYSEYSV | 2846 | Q02388 | |
| SLESYLSDYEEEPAE | 946 | Q92622 | |
| YDDVEYEEEPEAVDE | 246 | Q8N4B5 | |
| LDEESYSYDPEDEAS | 421 | Q92523 | |
| YLEPYSEEEEGQESS | 206 | O15259 | |
| RYYPEVNEEEEEPED | 681 | Q12756 | |
| PSPNEEESEDEEYYS | 331 | Q5HYW3 | |
| DELDTPDEADSFEYT | 2836 | Q8WUY3 | |
| IPSYIEPEDDYDDVE | 121 | Q6UWF3 | |
| PRSDSEESDSDYEEE | 631 | P51531 | |
| YASSDESEPDEAEPE | 6 | Q92733 | |
| RAEEEYEYAFDDEPT | 831 | O00267 | |
| SEYSELDEDESQAPY | 206 | P19387 | |
| TKEEEYEEEPYNEPA | 11 | Q8TEV9 | |
| PSYDEYADSDEDQHD | 436 | Q08945 | |
| DYEDDPKSDYSSENE | 806 | P35712 | |
| YDSEEEEESRPMSYD | 631 | P25440 | |
| LDSEESYPYEATEES | 196 | P07711 | |
| QELDYEEPDYEESSS | 251 | Q0P6D6 | |
| QEDDYEDDKPTNYSE | 1131 | P25054 | |
| EEDDDYENSTPPYKD | 21 | Q6ZS10 | |
| EEEDDDYENSTPPYK | 46 | Q6ZS10 | |
| EEEEDDDYENSTPPY | 71 | Q6ZS10 | |
| AYDEDEDEELYPDIH | 156 | Q96A61 | |
| EEEETTDDPEYDPGY | 51 | Q96B54 | |
| YDETTVDPNDEEVAY | 111 | Q9H9Y2 | |
| DTSVYESPYSDPEEL | 311 | P43403 | |
| DYTEPVADNETDYVE | 866 | Q8NB66 | |
| SDPEKDEDDDDNYYI | 2101 | O60673 | |
| EPEQSDGEEDFYYTE | 231 | Q9NR83 | |
| EASEDDYEYEEIPDD | 51 | Q8N0X2 | |
| PDREEEYYTEPEVAE | 141 | Q96J42 | |
| PEPVSDNEEDSYDEE | 121 | Q07157 | |
| RDDYDPDASLEYSEE | 221 | Q15695 | |
| EYYPEEDEELESAED | 21 | Q9H7L9 | |
| EPSGPYESDEDKSDY | 221 | Q04725 | |
| HITEEEDDDPDVYYF | 476 | Q8IYH5 | |
| EDDDPDVYYFESDHV | 481 | Q8IYH5 | |
| RDDYDPDASLEYSEE | 216 | Q15696 | |
| ITPDGADVYSYDEDD | 251 | P45974 |